Recently, it has been shown that high levels of IL-6 in the blood could induce activation of pro-angiogenic growth factors, such as vascular endothelial growth factor, which is implicated in the progression of CNV and AMD as well.37 In the future, IL-6 may be a possible novel target for AMD therapy. Here, IL6 is linked to age-related macular degeneration.